SCHEMBL2886978

SCHEMBL2886978

CCOC(=O)c1nc(C#N)c2nc(-c3cccc(OC)c3)sc2c1O

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 5/20 0.46
ALDH1A1 P00352 6/20 0.46
HPGD P15428 5/20 0.46
KDM4E B2RXH2 4/20 0.46
HSD17B10 Q99714 3/20 0.46
USP2 O75604 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MEN1 O00255 1/20 0.44
MAPT P10636 1/20 0.44
KMT2A Q03164 1/20 0.44
CDC7 O00311 5/20 0.43
DBF4 Q9UBU7 5/20 0.43
DHODH Q02127 1/20 0.40
GAA P10253 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TP53 P04637 1/20 0.40
ELANE P08246 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2884428 0.87 TRPM8 (0.55) TRPM8SMN1; SMN2MAPTCDC7DBF4
SCHEMBL2883384 0.86 ALDH1A1 (0.48) TRPM8ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL2880873 0.83 EGLN1 (0.51) TP53
SCHEMBL2881034 0.82 TRPM8 (0.56) TRPM8HPGDKDM4ESMN1; SMN2MEN1
SCHEMBL2886345 0.79 ALDH1A1 (0.48) TRPM8ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL2880599 0.76 CDC7 (0.50) TRPM8ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL2885696 0.76 TRPM8 (0.42) TRPM8ALDH1A1MEN1MAPTKMT2A
SCHEMBL2881560 0.75 CDC7 (0.63) TRPM8ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL2885217 0.74 RARA (0.49) TRPM8ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL2880630 0.73 TRPM8 (0.57) TRPM8ALDH1A1HPGDKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3124489-B1 THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS FIBROGEN INC (US) 2020-07-15 EP disclosed
EP-3124489-A1 THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS Fibrogen, Inc. (US) 2017-02-01 EP disclosed
EP-2016078-B1 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS FIBROGEN INC (US) 2016-06-15 EP disclosed
US-7696223-B2 [(2-bromo-4-hydroxy-1-phenyl-1H-pyrrolo[2,3-c]pyridine-5-carbonyl)-amino]-acetic acid; modulates the stability and/or activity of hypoxia inducible factor (HIF) FIBROGEN, INC. (US) 2010-04-13 US disclosed
US-20080004309-A1 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF FIBROGEN, INC. 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004309-A1 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF HIF1AN, HIF1A, EGLN2 TRPM8 3499/4885ALDH1A1 1047/4885HPGD 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.